期刊文献+

宫颈癌患者人乳头瘤病毒基因分型的研究 被引量:11

The Study of Human Papillomavirus Genotyping in Cervical Cancer
下载PDF
导出
摘要 目的探讨宫颈癌患者人乳头瘤病毒(HPV)基因分型的临床意义。方法采用导流杂交基因芯片技术对1169例宫颈癌患者脱落细胞标本进行HPV检测并分型。结果 1169例宫颈癌患者HPV感染率为91.70%(1072/1169),其中HPV单一感染率为77.16%(902/1169),多重感染率为14.54%(170/1169)。检出率较高的HPV基因型有HPV16(62.10%)、HPV18(10.95%)、HPV58(10.52%)、HPV52(7.96%)、HPV33(3.93%);宫颈非鳞癌组HPV18基因型感染率为12.99%,高于鳞癌组的6.87%,差异有统计学意义(χ2=3.994,P<0.05)。结论本地区宫颈癌患者常见HPV基因型的分布符合亚洲地区的分布规律,同时又有一定的区域性。HPV18基因型和非鳞癌组织类型有关,宫颈癌HPV基因型分布有助于确定宫颈癌发生的高危因素及筛查高危人群,对本地区HPV疫苗开发、应用具有重大意义。 Objective To investigate the clinical significance of detection on Human Papillomavirus(HPV) Genotypes in Patients with cervical cancer.Methods Flow-through hybridization and gene chip was used to detect HPV genotypes in specimens of exfoliated cells from 1169 cervical cancer patients.Results In 1 169 cases the infection rate of HPV was 91.70%(1 072/1 169),the rate of single genotype of HPV was 77.16%(902/1169),the rate of multiple genotypes of HPV was 14.54%(170/1169),The most common genotypes were HPV l6(62.10%),HPV18(10.95%),HPV58(10.52%),HPV52(7.96%),HPV33(3.93%).The infection rate of HPV18 in cervical nonsquamous cell cancer was 12.99%,which in cervical squamous cell cancer was 6.87%,HPV18 infection was more common in patients of nonsquamous cell cancer(χ^2=3.994,P〈0.05).Conclusion The prevalence of main HPV genotypes in cervical cancer in Zhejiang province is accordant to that of Asia,and also has its own character.HPV18 is significant related with nonsquamous histology.The study can help to determine the high-risk factors and groups of cervical cancer,and may be of great value for the promotion,research and development of HPV vaccine in our region.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第17期1871-1873,共3页 Chinese General Practice
关键词 宫颈肿瘤 乳头状瘤病毒 基因型 Cervix neoplasms Papillomavirus human Genotype
  • 相关文献

参考文献13

  • 1Cai HB,Ding XH,Chen CC.Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei,China[J].Oncology,2009,76:157-161.
  • 2Benedet JL,Bender H,Jones H,et al.FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers.FIGO committee on gynecologic oncology[J].Int J Gynaecol Obstet,2000,70(2):209-262.
  • 3Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta analysis[J].Br J Cancer,2003,88:63-73.
  • 4Wu EQ,Zhang GN,Yu XH,et al.Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in sichuan province of China[J].BMC Cancer,2008,8:202-206.
  • 5Ho CM,Chien TY,Huang SH,et al.Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer,and high viral loads predict risk of cervical cancer[J].Gynecol Oncol,2006,102(1):54-60.
  • 6Wu Y,Chen Y,Li L,et al.Associations of high-risk HPV types and viral load with cervical cancer in China[J].J Clin Virol,2006,35(3):264-269.
  • 7Prétet JL,Jacquard AC,Carcopino X,et al.Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France:EDITH study[J].Int J Cancer,2008,122:428-432.
  • 8Mejlhede N,Bonde J,Fomsgaard A.High frequency of multiple HPV types in cervical specimens from Danish women[J].APMIS,2009,117(2):108-114.
  • 9Khair MM,Mzibri ME,Mhand RA,et al.Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women[J].J Med Virol,2009,81(4):678-684.
  • 10Lai CH,Chang CJ,Huang HJ,et al.Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery[J].J Clin Oncol,2007,25(24):3628-3634.

二级参考文献23

  • 1陈家林,邓超干,许晓清,曹明清,沈彦珍,卢文深.基因芯片对尖锐湿疣患者HPV的检测和基因分型[J].河北医学,2006,12(2):105-107. 被引量:10
  • 2何桂蓉,李芳芳,何林,甘志彪,方红辉.反向斑点杂交技术应用于人乳头瘤病毒基因分型的研究[J].中华检验医学杂志,2006,29(7):658-658. 被引量:18
  • 3石菊芳,吴瑞芳,刘植华,周庆芝,李霓,乌兰娜,李晴,王倩,刘彬,李瑞珍,乔友林.深圳妇女人乳头瘤病毒的型别分布[J].中国医学科学院学报,2006,28(6):832-836. 被引量:37
  • 4[1]Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55 (2):74-108.
  • 5[2]Insinga RP,Dasbach EJ,Elbasha EH.Assessing the annual economic burden of preventing and treating anogenital human papillomavirua-related disease in the US:analytic framework and review of the literature[J].Pharmacoeconomics,2005,23 (11):1107-1122.
  • 6[3]Datta GD,Colditz GA,Kawachi I,et al.Individual-,neighborhood-,and state-level socioeconomic predictors of cervical carcinoma screening among U.S.black women:a multilevel analysis[J].Cancer,2006,106 (3):664-669.
  • 7[4]Newmann SJ,Garner EO.Social inequities along the cervical cancer continuum:a structured review[J].Cancer Causes Control,2005,16(1):63-70.
  • 8[5]Hoyo C,Yarnall KS,Skinner CS,et al.Pain predicts non-adherence to pap smear screening among middle-aged African American women[J].Prev Med,2005,41 (2):439-445.
  • 9[6]de Villiers EM,Fauquet C,Broker TR,et al.Classification of papillomaviruses[J].Virology,2004,324 (1):17-27.
  • 10[7]Moscicki AB,Schiffman M,Kjacr S,et al.Chapter 5:Updating the natural history of HPV and anagenital cancer[J].Vaccine,2006,24[Suppl 3]:42-51.

共引文献4

同被引文献82

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部